Thyroid gland: Revised guidelines for the management of thyroid cancer

Nature Reviews Endocrinology

Volumn 6, Issue 4, 2010, Pages 185-186

  Boelaert, Kristien ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; PROTEIN TYROSINE KINASE INHIBITOR;

ASPIRATION BIOPSY; CANCER RECURRENCE; CANCER RISK; CLINICAL PRACTICE; HUMAN; LOBECTOMY; MEDICAL RESEARCH; MEDICAL SOCIETY; NECK DISSECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; SHORT SURVEY; THYROID CANCER; THYROID NODULE; THYROIDECTOMY; UNSPECIFIED SIDE EFFECT;

CARCINOMA, PAPILLARY; HUMANS; NECK DISSECTION; NEOPLASM METASTASIS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE MEDICINE; THYROID GLAND; THYROID NEOPLASMS;

EID: 77950195949     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2010.17     Document Type: Short Survey

References (10)

1. Cooper, D. S. et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16, 109-142 (2006).
2. Cooper, D. S. et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167-1214 (2009).
3. Puxeddu, e. & Filetti, s. The 2009 American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: progress on the road from consensusto evidence-based practice. Thyroid 19, 1145-1147 (2009).
4. British Thyroid Association & Royal College of Physicians. Guidelines for the Management of Thyroid Cancer (ed. P. Perros) 2nd edition [online], http://www.british-thyroid-association.org/ Guidelines/ (2007).
5. Hartl, D. M. & Travagli, J. P. The updated American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: a surgical perspective. Thyroid 19, 1149-1151 (2009).
6. Mazzaferri, e. L., Doherty, G. M. & steward, D. L. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19, 683-689 (2009).
7. white, M. L., Gauger, P. G. & Doherty, G. M. Central lymph node dissection in differentiated thyroid cancer. World J. Surg. 31, 895-904 (2007).
8. sosa, J. A. et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann. Surg. 228, 320-330 (1998).
9. Gupta-Abramson, v. et al. Phase ii trial of sorafenib in advanced thyroid cancer. J. Clin. Oncol. 26, 4714-4719 (2008).
10. sherman, s. i. et al. Motesanib diphosphate in progressive differentiated thyroid cancer. N. Engl. J. Med. 359, 31-42 (2008).